Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Heesen

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2007
Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre studyD Pöhlau, H Przuntek, M Sailer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2013
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trialS Briken, S M Gold, S Patra, et al.
AJNR. American Journal of Neuroradiology|January 7, 2017
T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple SclerosisC Thaler, T D Faizy, J Sedlacik, et al.
International Journal of Nursing Studies|October 7, 2017
Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - Feasibility testing, pilot randomised controlled trial and mixed methods process evaluationA C Rahn, S Köpke, I Backhus, et al.
Neuroradiology|January 15, 2003
Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic strokeT Kucinski, C Koch, B Eckert, et al.
Der Nervenarzt|May 10, 2015
[Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research]J-P Stellmann, K H Stürner, F Ufer, et al.
Brain, Behavior, and Immunity|July 13, 2010
Correlates of cognitive dysfunction in multiple sclerosisC Heesen, K H Schulz, J Fiehler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2012
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patientsA Hofmann, J P Stellmann, J Kasper, et al.
Acta Neurologica Scandinavica|December 6, 2017
Perceptions on the value of bodily functions in multiple sclerosisC Heesen, R Haase, S Melzig, et al.
Clinical Rehabilitation|April 14, 2016
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): a controlled rater-blinded studyS Köpke, J Kasper, P Flachenecker, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2007
Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre studyD Pöhlau, H Przuntek, M Sailer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2013
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trialS Briken, S M Gold, S Patra, et al.
AJNR. American Journal of Neuroradiology|January 7, 2017
T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple SclerosisC Thaler, T D Faizy, J Sedlacik, et al.
International Journal of Nursing Studies|October 7, 2017
Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - Feasibility testing, pilot randomised controlled trial and mixed methods process evaluationA C Rahn, S Köpke, I Backhus, et al.
Neuroradiology|January 15, 2003
Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic strokeT Kucinski, C Koch, B Eckert, et al.
Der Nervenarzt|May 10, 2015
[Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research]J-P Stellmann, K H Stürner, F Ufer, et al.
Brain, Behavior, and Immunity|July 13, 2010
Correlates of cognitive dysfunction in multiple sclerosisC Heesen, K H Schulz, J Fiehler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2012
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patientsA Hofmann, J P Stellmann, J Kasper, et al.
Acta Neurologica Scandinavica|December 6, 2017
Perceptions on the value of bodily functions in multiple sclerosisC Heesen, R Haase, S Melzig, et al.
Clinical Rehabilitation|April 14, 2016
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): a controlled rater-blinded studyS Köpke, J Kasper, P Flachenecker, et al.
Pageof 8